Delivery Order SPE2DB20D3103-SPE2DB26FL3S4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,766.11 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on September 11, 2025, with completion scheduled for September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors with a ceiling value of $1,285.13. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors on August 28, 2025, with a ceiling value of $5,441.80. This non-competitive delivery order, valued at firm fixed price, is set to be completed by August 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a single delivery transaction under the company's existing contract vehicle with the DLA....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,760.19 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors on September 25, 2025, with completion targeted for September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,446.90 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a $21,011.11 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The order will be fulfilled from the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $32,650.80 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors. This firm fixed-price, competitively awarded delivery order is set to be completed by September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,360.45 for Mounjaro 15 mg/0.5 ml pen injectors on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL3S4Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $21,767.20 on October 23, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors. This non-competitive delivery order represents a firm fixed-price purchase under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 24, 2025. As a comprehensive pharmaceutical prime vendor contract, the underlying IDC enables AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated extensive capability in fulfilling federal medical procurement requirements through competitive award processes. This delivery order for the diabetes medication Mounjaro reflects the company's established role as a critical vendor for the Defense Health Agency and other federal healthcare systems. The award follows DLA's historical pattern of utilizing established pharmaceutical prime vendor contracts to efficiently procure essential medical commodities across multiple therapeutic categories, enabling rapid fulfillment of military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 10/23/25 |